According to Xintian Technology's announcement, the cumulative closing price increase of the company's stock deviated from 100.90% from August 3 to 6, 2026, and a cumulative deviation of 41.83% from August 5 to 6, which was an abnormal and serious abnormal fluctuation. The company is currently operating normally, and the controlling shareholder Shi Weiping did not trade shares during the change period. The issuance of shares to specific targets in 2025 was not submitted to the Shenzhen Stock Exchange for review; on July 31, 2026, shareholders of Shi Weiping planned to transfer 22.4999% of the shares to Shenzhen Yuanqi at a transfer price of 720 million yuan, which still requires compliance confirmation and transfer. The transferee promised no asset injection plan for 36 months. In addition, the company expects a net loss of 368-50.8 million yuan for the 2026 semi-year.

According to Xintian Technology's announcement, the cumulative closing price increase of the company's stock deviated from 100.90% from August 3 to 6, 2026, and a cumulative deviation of 41.83% from August 5 to 6, which was an abnormal and serious abnormal fluctuation. The company is currently operating normally, and the controlling shareholder Shi Weiping did not trade shares during the change period. The issuance of shares to specific targets in 2025 was not submitted to the Shenzhen Stock Exchange for review; on July 31, 2026, shareholders of Shi Weiping planned to transfer 22.4999% of the shares to Shenzhen Yuanqi at a transfer price of 720 million yuan, which still requires compliance confirmation and transfer. The transferee promised no asset injection plan for 36 months. In addition, the company expects a net loss of 368-50.8 million yuan for the 2026 semi-year.